Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial

NACompletedINTERVENTIONAL
Enrollment

2,637

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

December 11, 2019

Study Completion Date

June 3, 2020

Conditions
Medication Review
Interventions
PROCEDURE

Comprehensive medication review

"* A thorough medication reconciliation, including a patient/carer interview, by a clinical pharmacist.~* The clinical pharmacist performs a comprehensive medication review in collaboration with the ward physician and patient, similar to a level three clinical medication review as earlier described in the literature \[4\]. This includes a structured, critical examination of all of the patient's medications in relation to the patient's conditions, based on information from the patient and the medical record. The objective is to optimise the impact of medications and minimizing the number of medication-related problems. The effects of medication changes will be monitored during the hospital stay by the physician or pharmacist, depending on the specific situation.~* Before discharge, the clinical pharmacist performs another medication reconciliation to check if the patient's prescriptions for medications to be used after hospital stay are consistent with the patient's medical record."

PROCEDURE

Comprehensive medication review with active follow-up

"The same as I1 but with the following additions:~* In case of any monitoring needs or necessary subsequent actions to be taken after hospital discharge, the clinical pharmacist and the ward physician send an electronic medication review referral to the patient's primary care physician upon discharge.~* A first phone call to the patient or carer is made by the clinical pharmacist 2-7 days after the patient is discharged depending on health condition and the pharmacist's availability. This phone call aims to ensure that all information has been understood correctly and to find out if any problems, concerns or questions have arisen after discharge.~* A second phone call will be made by the clinical pharmacist approximately 30 days after hospital discharge. This phone call aims to find out how the patient is managing the medication and if any problems, concerns or questions have arisen, and to provide the patient with a motivational boost."

PROCEDURE

Usual Care

The control group will receive usual hospital care. According to Swedish legislation, usual care includes medication reconciliation upon admission. Next to that, the law requires a medication report addressing the patient's medication treatment to be given to the patient or carer upon hospital discharge and to be attached to the electronic discharge letter. This report contains a motivation and explanation to the changes in medication treatment that have been made during hospital stay, as well as the patient's updated medication list. These mandatory activities are currently carried out to various degree within the different hospitals and wards. Other activities as described in the interventions above may be carried out to a certain degree as well, but no clinical pharmacist will be involved.

Trial Locations (4)

72334

Västmanland Hospital, Västerås

74538

Enköping Hospital, Enköping

75185

Uppsala University Hospital, Uppsala

80324

Gävle Hospital, Gävle

All Listed Sponsors
collaborator

Region Gävleborg

OTHER

collaborator

Västmanland County Council, Sweden

OTHER_GOV

collaborator

Uppsala University

OTHER

collaborator

Uppsala Clinical Research Center, Sweden

UNKNOWN

lead

Uppsala County Council, Sweden

OTHER_GOV

NCT02999412 - Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial | Biotech Hunter | Biotech Hunter